New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Metabolic Mind2 Joulu 2025

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

Novo Nordisk, the pharmaceutical company behind popular GLP-1 medications like Wegovy and Ozempic, recently announced that its phase 3, two-year trial examining GLP-1 medications for Alzheimer's failed to produce a significant reduction in disease progression.

While these results are discouraging, they may have revealed something vital about Alzheimer’s treatment.

In this video, Dr. Bret Scher breaks down the recent failure of Novo Nordisk’s evoke and evoke+ trials and what it teaches us about the limitations of a drug-only approach to Alzheimer’s treatment.

Key topics covered:

  • Why GLP-1s may not be enough for Alzheimer’s
  • The link between glucose metabolism and brain energy failure
  • How ketones offer an alternative fuel for the brain
  • Early research on ketogenic therapy for cognitive impairment
  • Why nutritional interventions deserve more scientific attention

With Alzheimer’s affecting millions and costing billions, it’s time to shine a light on metabolic strategies that directly support brain energy, reduce inflammation, and improve cognitive function.

🧠 Explore our full playlist on ketogenic therapy for Alzheimer’s and cognitive decline: https://www.youtube.com/playlist?list=PLzWI83-NWCL4f7uVRIWUHCC2nF6t_5DLw

#MetabolicMind #KetogenicTherapy #Alzheimers

Expert Featured:

Dr. Bret Scher



Resources Mentioned:

Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression


Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US


Brain energy rescue with ketones improves cognitive outcomes in MCI


Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease


Ketogenic strategies for Alzheimer’s disease and other memory impairments: History, rationale, and 288 caregiver case reports


Metabolic Mind Ketogenic Therapy for Dementia Playlist



Free CME Clinician Trainings:

Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein and Dr. Bret Scher with more coming soon.

Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:

https://www.metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-yt


Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.

Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/


About us:

Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.

Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

Jaksot(185)

New Study Questions LDL Risk - An interview with Dave Feldman

New Study Questions LDL Risk - An interview with Dave Feldman

Do we all have to worry that LDL causes heart disease, or could certain people, like low-carb "lean mass hyper responders" have less concern about LDL and heart risk? A new study from Dave Feldman and...

31 Tammi 202441min

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?

What Do Adenosine, Forests & Keto Diets Have to do with Brain Health?

At Metabolic Mind, we often focus on ketogenic therapy as a treatment for severe mental illnesses like bipolar, schizophrenia, and depression. But it’s important to realize that a keto diet can also b...

15 Tammi 202417min

Can Changing Your Diet Change Your Mind?- with Metabolic Psychiatry Pioneer Dr. Georgia Ede

Can Changing Your Diet Change Your Mind?- with Metabolic Psychiatry Pioneer Dr. Georgia Ede

Is the key to optimizing physical and mental health eating so-called superfoods like dark chocolate, red wine and blueberries? Dr. Georgia Ede, a Harvard-trained psychiatrist and metabolic psychiatry ...

8 Tammi 202439min

Future of Precision Medicine & Nutritional Therapies for Mental Illness with Dr. Megan Kirk Chang

Future of Precision Medicine & Nutritional Therapies for Mental Illness with Dr. Megan Kirk Chang

Dr. Megan Kirk Chang, Senior Researcher of Medical Science at the University of Oxford, discusses her upcoming trials looking at nutritional interventions: one focuses on ketosis for treatment-resista...

2 Tammi 202433min

GLP-1 and Ketosis: Novel Mental Health Treatments

GLP-1 and Ketosis: Novel Mental Health Treatments

GLP1 medications like Wegovy and Ozempic can help with weight loss but may also be able to help with psychiatric symptoms from depression, bipolar disorder, anxiety, and more. But are GLP1s safe in ps...

26 Joulu 202339min

Treating Bipolar with Keto - 100 Self-Reports with Dr. Iain Campbell

Treating Bipolar with Keto - 100 Self-Reports with Dr. Iain Campbell

Ketogenic diets are emerging as an exciting new alternative treatment for bipolar disorder and other psychiatric conditions. Many people may see remission of their psychiatric symptoms and may be able...

18 Joulu 202321min

Ketosis and Depression: An inspiring personal story from Stanford's Healthcare Innovation Lab.

Ketosis and Depression: An inspiring personal story from Stanford's Healthcare Innovation Lab.

Ben Rolnik lived with depression, thinking often about suicide, and even when he was doing well, he never knew if his day would get upended by depressive symptoms. That all changed when he found ketog...

11 Joulu 202347min

Psychiatrist Shares His Experience With GLP1 Weight Loss Drugs with Dr Rodrigo Mansuer

Psychiatrist Shares His Experience With GLP1 Weight Loss Drugs with Dr Rodrigo Mansuer

GLP1 agonist weight loss medications Wegovy and Ozempic have become popular medications for overweight and obesity and are also increasingly being used in psychiatry to target symptoms of depression a...

4 Joulu 202320min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
rss-pitaisko-erota
rss-narsisti
puhu-muru
rss-kuumilla-aalloilla
rss-pt-paahtio
meditaatiot-suomeksi
selviytyjat-tarinoita-elamasta
terapiassa
fitnesskulmapodcast
junnut-pelissa
rss-nautinto
audio-sport-juoksu
fitnessvastaanotto
rss-addiktit
rss-seuraava-potilas